DOHA, QATAR – 23/02/2026 – () – Following its presentation at Web Summit Qatar 2026, Stellora.AI has unveiled a strategic shift that makes Quantum-Bio Research the core of its long-term strategy. The European deep-tech firm is transitioning from infrastructure-oriented AI solutions to focus on quantum-powered medical breakthroughs, calling on research organizations and impact-driven investors to partner on major healthcare advancements.
During the event, Stellora.AI showcased its proprietary Agentic Multilayer RAG (Retrieval-Augmented Generation) engine and Quantum Flow framework—technologies engineered to produce highly accurate, verifiable AI results in sophisticated computing settings. While global AI conversations have largely focused on commercial implementation, Stellora.AI highlighted how quantum-integrated platforms could speed up advances in life sciences and biomedical studies.
Advancing Healthcare Through Quantum Infrastructure
The firm is currently refining its “Sovereignty First” infrastructure to enable three key focus areas:
- Molecular Simulation and Drug Discovery: Utilizing Quantum Processing Units (QPUs), Stellora.AI seeks to simulate chemical reactions and molecular behaviors that surpass the capabilities of traditional computers, possibly accelerating the drug development process.
- Precision Medicine: The agentic AI system is built to examine and verify extensive datasets, supporting more personalized treatment approaches in areas like oncology, neurology, and other specialized medical fields.
- Longevity and Disease Modeling: Using synchronized AI agent “swarms,” the platform can independently improve hypotheses concerning biological aging and intricate disease development.
According to founder Michal Charvát, the company’s infrastructure is already running on production-grade systems and backed by quantum hardware trials. He indicated that the upcoming phase will emphasize expanding implementations through partnerships with research hospitals, labs, and universities globally.
Agentic Orchestration and Quantum Flow Integration
At the heart of Stellora.AI’s technical methodology is its Multilayer RAG engine, which utilizes numerous specialized AI agents to repeatedly verify results before final output. This multi-tiered validation approach aims to minimize errors in critical research settings where data accuracy is paramount.
Integrated with the Quantum Flow framework, the platform can create, evaluate, and refine quantum algorithms directly within active quantum computing ecosystems, such as IBM Quantum and AWS Braket. By connecting AI-powered logic with quantum hardware operations, Stellora.AI aims to tackle what it calls the “computation gap” that constrains present-day scientific modeling capacity.
Opening the Door to Strategic Collaboration
Acknowledging that quantum-enhanced biomedical research requires substantial funding and cross-disciplinary knowledge, Stellora.AI has officially started talks with impact investors, VC firms, and research bodies. The firm intends to grow its R&D capacity while offering its technologies to non-profit and purpose-driven groups that share its healthcare mission.
In the longer term, Stellora.AI has also articulated an expanded vision: creating smart computational frameworks that can sustain human health and data autonomy in upcoming space exploration missions. The company frames this goal as a natural progression of its health-centric approach, guaranteeing robust digital and biological systems in progressively challenging conditions.
About Stellora.AI
Stellora.AI, previously called LunaPro.AI, is a European deep-tech enterprise focused on multilayer Retrieval-Augmented Generation platforms built for accuracy, performance, and dependability. Through combining agent-based AI coordination with quantum-ready processes, the firm delivers sophisticated computational intelligence for industries such as healthcare, advanced technology, and space exploration.